Amylin/calcitonin receptor (dual) drugs for Type 2 Diabetes

2 tracked Amylin/calcitonin receptor (dual) drugs in the Type 2 Diabetes race. The class explanation lives on the Amylin/calcitonin receptor (dual) page; the full indication pipeline across every mechanism is on the Type 2 Diabetes page.

2 Phase 3

Head-to-head evidence: cagrilintide vs cagrilintide/semaglutide

The roster

← all Amylin/calcitonin receptor (dual) drugs